As Australia contemplates opening its tightly controlled borders and finding a way to live with COVID-19, private equity probes an opportunity set in transition yet surprisingly stable
Having rebounded strongly from severe lockdowns last year, Australia appeared on track to be the first market in Asia Pacific that could be truly described as a post-pandemic economy. The subsequent outbreak...
India’s Innoven Capital, a joint venture between UOB and Temasek Holdings-owned Seviora Holdings, has fractionalised a USD 50m venture debt fund using blockchain and smart contracts.
OneVentures and UniQuest have led a AUD 34m (USD 23m) funding round for Vaxxas, an Australia-based biotechnology company running clinical programmes that include a needle-free COVID-19 vaccine candidate.
Temasek Holdings, A91 Partners, and Kae Capital have invested USD 135m in Indian omnichannel wellness products retailer HealthKart.
Northleaf Capital Partners, a Canada-based asset manager that invests in private equity, private credit, and infrastructure, has opened a Tokyo office to spearhead fundraising activity in Asia and is considering the addition of a Korea presence.